Patricia Levy Zusman International Workshop on Neuroregeneration (Zusman Workshop)

Patricia Levy Zusman 神经再生国际研讨会(Zusman 研讨会)

基本信息

  • 批准号:
    10607404
  • 负责人:
  • 金额:
    $ 2.2万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-12-15 至 2023-12-14
  • 项目状态:
    已结题

项目摘要

Project Summary/Abstract This R13 originated through discussions with investigators in the fields of neurostimulation and neuroplasticity at the Houston Methodist Research Institute (HMRI). In 2017, we held an R13-funded pilot workshop that combined research in neural stimulation with new insight into the molecular understanding of neural plasticity and regeneration. The workshop received a strong, positive response by participants and interest in further catalysts of working collaboration. Thus, in 2019, we fostered relationship development and crossover opportunities among attendees via a blitz session wherein newly formed (i.e., established at the 2019 Workshop) collaborative teams competed for two $5K mini grants that supported travel to and from each other’s institutions. In 2021, our R13-funded workshop went 100% virtual due to COVID-19; however, this did not diminish the Workshop’s impact. With over eighty attendees, many new collaborations were forged, and projects conceived. Given the overwhelmingly positive feedback, we will host the 4th Patricia Levy Zusman International Workshop on Neuroregeneration (Zusman Workshop) on March 7th-10th, 2023. It will focus on the intersection of electrical activity, brain connectomics and molecular neural plasticity. Our specific aims are to: 1) formulate new ideas to fill the gap between physiology and functional-based brain stimulation technologies and the molecular and cellular understanding of innate neuronal plasticity; 2) integrate promising trainees into plenary sessions; and 3) ensure trainees participate in substantial discussions and interactions with faculty members. The 2023 Workshop will be held at HMRI, which is part of the Texas Medical Center (TMC; a one-of-a-kind medical and research hub that fosters cross-institutional collaboration, creativity, and innovation) and is in Houston Texas (one of the United States’ most diverse cities). A key aspect of the Zusman Workshop is the active inclusion and participation of trainees, particularly women and under-represented minorities. We will encourage their participation via travel scholarships and active promotion and recruitment throughout the TMC. Also, the Workshop seeks to promote the voices of graduate and postdoctoral trainees. As such, it will include a trainee poster session as well as a session dedicated to trainee oral presentations (given by travel awardees). Further, goal-oriented breakout sessions, led by senior/early-stage investigators and selected trainees, will foster discussion and promote cross- training and collaboration among participants. Overall, this workshop is distinct from established physiology conferences and dedicated neural regeneration conferences in several ways. It is: 1) highly focused on the gap between molecular regeneration and electrophysiology/stimulation, 2) concept driven by clinicians and experimentalists currently problem solving in human therapy, and 3) focused on the establishment of cross training and expertise development in graduate, post-graduate, and clinical fellows. The 2023 Zusman Workshop will ignite innovative collaborations and spur novel multidisciplinary teams to develop innovative, transdisciplinary methods, technologies, and treatments to modulate performance in the damaged nervous system.
项目总结/摘要 这个R13起源于与神经刺激和神经可塑性领域的研究人员的讨论 休斯顿卫理公会研究所(Houston Methodist Research Institute,HMRI)2017年,我们举办了一个由R13资助的试点研讨会, 结合神经刺激的研究和对神经可塑性的分子理解的新见解 和再生。研讨会得到了与会者的强烈、积极的响应,并有兴趣进一步 工作合作的催化剂。因此,在2019年,我们促进了关系发展和交叉 经由闪电会议在出席者之间的机会,其中新形成的(即,(2019年研讨会) 协作团队竞争两个5000美元的小型赠款,用于支持往返彼此机构的旅行。 在2021年,我们的R13资助的研讨会由于COVID-19而100%虚拟化;然而,这并没有减少 车间的影响。有超过80名与会者,许多新的合作被伪造,项目构思。 鉴于压倒性的积极反馈,我们将主办第四届帕特里夏·利维·祖斯曼国际研讨会 2023年3月7日至10日,神经再生(Zusman研讨会)。它将集中在电气的交叉点 活动,脑连接组学和分子神经可塑性。我们的具体目标是:1)制定新的想法, 填补了基于生理和功能的脑刺激技术与分子之间的差距, 先天神经元可塑性的细胞理解; 2)将有前途的学员纳入全体会议; 3) 确保学员参与实质性的讨论和互动与教师。2023工作坊 将在HMRI举行,HMRI是德克萨斯医疗中心(TMC;独一无二的医疗和研究中心)的一部分 促进跨机构合作,创造力和创新),位于德克萨斯州休斯顿(美国 最多样化的城市)。Zusman研讨会的一个关键方面是积极包容和参与, 学员,特别是妇女和代表性不足的少数群体。我们将鼓励他们通过旅行参与 奖学金和积极推广和整个TMC招聘。此外,讲习班还力求促进 研究生和博士后学员的声音。因此,它将包括一个学员海报会议以及一个 专门用于学员口头报告的会议(由旅行获奖者提供)。进一步,目标导向突破 由高级/早期研究人员和选定的受训人员主持的会议将促进讨论, 培训和参与者之间的合作。总的来说,这个研讨会是不同于既定的生理学 会议和专门的神经再生会议在几个方面。它是:1)高度关注差距 分子再生和电生理学/刺激之间的关系,2)临床医生驱动的概念, 实验者目前在人类治疗中解决问题,3)专注于建立交叉 研究生、研究生和临床研究员的培训和专业知识发展。2023年Zusman研讨会 将点燃创新的合作,并刺激新的多学科团队开发创新的,跨学科的 方法、技术和治疗来调节受损神经系统的表现。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Philip J Horner其他文献

Philip J Horner的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Philip J Horner', 18)}}的其他基金

Spinal Neuromodulation to Promote Physiologic and Molecular Plasticity in theInjured Spinal Cord
脊髓神经调节促进受损脊髓的生理和分子可塑性
  • 批准号:
    10805726
  • 财政年份:
    2023
  • 资助金额:
    $ 2.2万
  • 项目类别:
Training in Neural Control of organ Degeneration and Regeneration (NeuralCODR)
器官退化和再生的神经控制培训(NeuralCODR)
  • 批准号:
    10620833
  • 财政年份:
    2022
  • 资助金额:
    $ 2.2万
  • 项目类别:
Training in Neural Control of organ Degeneration and Regeneration (NeuralCODR)
器官退化和再生的神经控制培训(NeuralCODR)
  • 批准号:
    10410250
  • 财政年份:
    2022
  • 资助金额:
    $ 2.2万
  • 项目类别:
A versatile reporter for visualization of myelin plasticity in the genetically modified rat
一种多功能报告基因,用于可视化转基因大鼠的髓磷脂可塑性
  • 批准号:
    10303241
  • 财政年份:
    2021
  • 资助金额:
    $ 2.2万
  • 项目类别:
CNS Neuroregeneration strategies: Discovery and Implementation
中枢神经系统神经再生策略:发现和实施
  • 批准号:
    9332048
  • 财政年份:
    2017
  • 资助金额:
    $ 2.2万
  • 项目类别:
Astrocyte-specific ligand discovery by phage display
通过噬菌体展示发现星形胶质细胞特异性配体
  • 批准号:
    8995701
  • 财政年份:
    2015
  • 资助金额:
    $ 2.2万
  • 项目类别:
Metabolic requirements of adult neural stem cells
成体神经干细胞的代谢需求
  • 批准号:
    8068094
  • 财政年份:
    2011
  • 资助金额:
    $ 2.2万
  • 项目类别:
Metabolic requirements of adult neural stem cells
成体神经干细胞的代谢需求
  • 批准号:
    8321500
  • 财政年份:
    2011
  • 资助金额:
    $ 2.2万
  • 项目类别:
Combined stem cell transplantation and targeted microstimulation to direct the fo
联合干细胞移植和定向微刺激来指导
  • 批准号:
    8288742
  • 财政年份:
    2009
  • 资助金额:
    $ 2.2万
  • 项目类别:
Ultrasound-aided gene transfer to direct cortical neurogenesis after brain injury
超声辅助基因转移至脑损伤后直接皮质神经发生
  • 批准号:
    8722168
  • 财政年份:
    2009
  • 资助金额:
    $ 2.2万
  • 项目类别:

相似海外基金

Countering sympathetic vasoconstriction during skeletal muscle exercise as an adjuvant therapy for DMD
骨骼肌运动期间对抗交感血管收缩作为 DMD 的辅助治疗
  • 批准号:
    10735090
  • 财政年份:
    2023
  • 资助金额:
    $ 2.2万
  • 项目类别:
The ESCAPE clinical trial of circulating tumor DNA to guide adjuvant therapy in chemo-resistant triple negative breast cancer
循环肿瘤 DNA 指导化疗耐药三阴性乳腺癌辅助治疗的 ESCAPE 临床试验
  • 批准号:
    494901
  • 财政年份:
    2023
  • 资助金额:
    $ 2.2万
  • 项目类别:
    Operating Grants
A Type I Hybrid Effectiveness-Implementation Trial to Evaluate a Navigation-Based Multilevel Intervention to Decrease Delays Starting Adjuvant Therapy Among Patients with Head and Neck Cancer
一项 I 型混合有效性实施试验,用于评估基于导航的多级干预措施,以减少头颈癌患者开始辅助治疗的延迟
  • 批准号:
    10714537
  • 财政年份:
    2023
  • 资助金额:
    $ 2.2万
  • 项目类别:
Multi-modal machine learning to guide adjuvant therapy in surgically resectable colorectal cancer
多模式机器学习指导可手术切除结直肠癌的辅助治疗
  • 批准号:
    10588103
  • 财政年份:
    2023
  • 资助金额:
    $ 2.2万
  • 项目类别:
Efficacy of ethanol adjuvant therapy after resection of malignant soft tissue tumors
恶性软组织肿瘤切除术后乙醇辅助治疗的疗效
  • 批准号:
    22K09407
  • 财政年份:
    2022
  • 资助金额:
    $ 2.2万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Identification of immune response cells and development of novel adjuvant therapy for sublingual immunotherapy
免疫应答细胞的鉴定和舌下免疫治疗新型辅助疗法的开发
  • 批准号:
    21KK0287
  • 财政年份:
    2022
  • 资助金额:
    $ 2.2万
  • 项目类别:
    Fund for the Promotion of Joint International Research (Fostering Joint International Research (A))
Pursuing molecular biomarkers to guide adjuvant therapy for HPV+ head and neck cancers after transoral robotic surgery
寻找分子生物标志物来指导经口机器人手术后 HPV 头颈癌的辅助治疗
  • 批准号:
    10357120
  • 财政年份:
    2022
  • 资助金额:
    $ 2.2万
  • 项目类别:
Biomarker research using two prospective studies on preoperative and postoperative adjuvant therapy for pancreatic cancer
使用两项关于胰腺癌术前和术后辅助治疗的前瞻性研究进行生物标志物研究
  • 批准号:
    21K08700
  • 财政年份:
    2021
  • 资助金额:
    $ 2.2万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Personalized Resistant Starch as an Adjuvant Therapy for Pediatric Inflammatory Bowel Disease
个性化抗性淀粉作为小儿炎症性肠病的辅助治疗
  • 批准号:
    437315
  • 财政年份:
    2020
  • 资助金额:
    $ 2.2万
  • 项目类别:
    Studentship Programs
Tailored adjuvant therapy in POLE-mutated and p53-wildtype early stage endometrial cancer (TAPER)
POLE 突变和 p53 野生型早期子宫内膜癌 (TAPER) 的定制辅助治疗
  • 批准号:
    435603
  • 财政年份:
    2020
  • 资助金额:
    $ 2.2万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了